New York, New York, United States Altium Capital is the famous VC, which was founded in 2017. The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.
The high activity for fund was in 2019. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars.
Besides, a startup needs to be aged 16-20 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Clinical Trials.
The current fund was established by Jacob Gottlieb. The overall number of key employees were 2.
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Platinum AM, Australian Ethical Investment.
Related Funds
| Fund Name | Location |
| Cresco | Japan, Tokyo |
| Edventures | Boise, Idaho, United States |
| Gaja Capital | India, Maharashtra, Mumbai |
| GFR Fund | California, San Francisco, United States |
| Handok | - |
| HD Capital | - |
| Japan BCG Laboratory | Japan, Tokyo |
| Jianzheng Touzi | China, Shanghai |
| Jiuhe Jinkong | Beijing, Beijing, China |
| Mercari | Chiyoda, Japan |
| NA | - |
| National Capital Consortium for Pediatric Device Innovation | - |
| Taicom Capital | Taipei, Taiwan |
| Techstars Accelerator | - |
| Tele-Communications, Inc | - |
| Transurban Group | Australia, Melbourne, Victoria |
| Yungpark Lingzhong Fund | - |
| Zhihe Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aligned | $34M | 24 Feb 2022 | - | ||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
Happy Co. | $10M | 26 Mar 2018 | San Francisco, California, United States |
– Antios Therapeutics from San Diego, CA announced the successful completion of a $96m Series B financing.
– The financing was led by Soleus Capital with participation from new major investors RA Capital Management, Adage Capital Management LP, Pontifax and Aisling Capital as well as other healthcare focused funds, Altium Capital, Amzak Health, Granite Point Capital Management, LP, and LifeSci Venture Partners and participation from all of the original Series A investors including Lumira Ventures, CAM Capital, Delos Capital, Domain Associates and Sixty Degree Capital.
– Antios Therapeutics is a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases.
– eGenesis from Cambridge, Mass. develops human-compatible organs, tissues, and cells.
– The company raised $125m in Series C funding.
– Backers included Farallon Capital Management, Polaris Partners, HBM Healthcare Investments, Invus, Samsara BioCapital, LifeSci Venture Partners, Irving Investors, Catalio Capital Management, SymBiosis, Altium Capital, Monashee Investment Management, and Osage University Partners and existing investors Leaps by Bayer, Fresenius Medical Care Ventures, ARCH Venture Partners, Wellington Partners, Khosla Ventures, and Alta Partners.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aligned | $34M | 24 Feb 2022 | - | ||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
Happy Co. | $10M | 26 Mar 2018 | San Francisco, California, United States |
